TY - JOUR T1 - How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England JF - medRxiv DO - 10.1101/2020.06.16.20132654 SP - 2020.06.16.20132654 AU - Chiamaka Chiedozie AU - Mark Murphy AU - Tom Fahey AU - Frank Moriarty Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/19/2020.06.16.20132654.abstract N2 - Aim To apply the DU90% indicator (the number of unique drugs which make up 90% of a doctor’s prescribing) to GP practices prescribing in England to examine time trends, practice-level variation, and relationships with practice characteristicsMethod This is an observational cohort study of all general practices in England. It utilises publicly available prescribing data from the National Health Service (NHS) Digital platform for 2013-2017. The DU90% was calculated on an annual basis for each practice based on medication BNF codes. Descriptive statistics were generated per year on time trends and practice-level variation in the DU90%. Multi-level linear regression was used to examine the practice characteristics (relating to staff, patients, and deprivation of the practice area).Results A total of 7,623 GP practices were included. The mean DU90% ranged from 130.1 to 133.4 across study years, and variation between practices was low (with a 1.4 fold difference between the lowest and highest 5% of practices). A range of medications were included in the DU90% of virtually all practices, including atorvastatin, levothyroxine, omeprazole, ramipril, amlodipine, simvastatin and aspirin. A higher volume of prescribing was associated with a lower DU90%, while having more patients, higher proportions of patients who are female or aged 65+, higher number of GPs working in the practice, and being in a more deprived area were associated with a higher DU90%.Conclusion GP practices typically use 130 different medications in the bulk of their prescribing. Increasing use of personal formularies may enhance prescribing quality and reduce costs.What is already known about this subject:Prescribers can develop expertise in a finite number of drugs, hence use of a personal formulary is recommended and may enhance prescribing qualityThe drug utilisation 90% (DU90%), a measure of the number of drugs that comprises 90% of prescribing volume, has not been applied to prescribing in England to date.What this study adds:On average, 130 medicines make up 90% of prescribing in GP practices in England.Practices with a lower DU90% tended to have lower prescribing costs and less prescribing considered low-value care.Rationalising prescribing to focus on a smaller group of medicines may enhance quality and reduce costs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Health Research Board in Ireland (HRB) through the Summer Student Scholarships (grant no. SS/2018/080) and the HRB Centre for Primary Care Research (HRC/2014/01), and supported by the Royal College of Surgeons in Ireland Undergraduate Research Summer School.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study reuses publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in Zenodo at https://doi.org/10.5281/zenodo.3894539.https://doi.org/10.5281/zenodo.3894539 ER -